- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CYAD
Recent news which mentions CYAD
Why First Wave BioPharma Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
January 17, 2023
From Benzinga
From InvestorPlace
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 22, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
From Benzinga
From InvestorPlace
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 21, 2022
From Benzinga
Celyad Oncology Completely Shifts To Preclinical Stage, Pulls Plug On Only Human Trial Asset
December 21, 2022
Tickers
CYAD
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 21, 2022
From Benzinga
From InvestorPlace
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
December 21, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Earnings Scheduled For August 5, 2022
August 05, 2022
From Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
From Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
From Benzinga
From Benzinga
U.S. Stocks Turn Negative; Dow Drops Over 100 Points
August 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 01, 2022
From Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
From Benzinga
U.S. Stocks Turn Higher; Crude Oil Tumbles
August 01, 2022
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 01, 2022
From Benzinga
From InvestorPlace
Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket
August 01, 2022
From Benzinga
FDA Removes Clinical Hold On Celyad's Colorectal Cancer Trial
August 01, 2022
From Benzinga
From Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.